{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:41:47Z","timestamp":1756384907934},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":544,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics &amp; Neonatology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.pedneo.2013.12.001","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T12:46:14Z","timestamp":1391258774000},"page":"306-311","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cyclic Pamidronate Infusion for Neonatal-onset Osteogenesis Imperfecta"],"prefix":"10.1016","volume":"55","author":[{"given":"Chia-Hsuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Hsiu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinn-Forng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ching","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Ching","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2013.12.001_bib1","unstructured":"Steiner RD, Adsit J, Basel D. COL1A1\/2-Related Osteogenesis Imperfecta. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews\u2122 [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132013."},{"key":"10.1016\/j.pedneo.2013.12.001_bib2","series-title":"The online metabolic and molecular bases of inherited disease (OMMBID)","article-title":"Disorders of collagen biosynthesis and structure","author":"Byers","year":"2013"},{"key":"10.1016\/j.pedneo.2013.12.001_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ejhg.2011.141","article-title":"EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta","volume":"20","author":"van Dijk","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pedneo.2013.12.001_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00350961","article-title":"Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta","volume":"16","author":"Devogelaer","year":"1987","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.pedneo.2013.12.001_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pedneo.2013.12.001_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","article-title":"Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta","volume":"86","author":"Astr\u00f6m","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pedneo.2013.12.001_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1542\/peds.111.3.573","article-title":"Intravenous bisphosphonate therapy in children with osteogenesis imperfecta","volume":"111","author":"Falk","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2013.12.001_bib8","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","article-title":"Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV","volume":"111","author":"Zeitlin","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2013.12.001_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1875-9572(09)60002-4","article-title":"Intravenous pamidronate therapy in Taiwanese patients with osteogenesis imperfecta","volume":"49","author":"Lin","year":"2008","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.pedneo.2013.12.001_bib10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1359\/JBMR.050312","article-title":"Intravenous bisphosphonate therapy increases radial width in adults with osteogenesis imperfecta","volume":"20","author":"Gatti","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pedneo.2013.12.001_bib11","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1542\/peds.2006-2023I","article-title":"Experience with bisphosphonates in osteogenesis imperfecta","volume":"119","author":"Glorieux","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2013.12.001_bib12","first-page":"261","article-title":"Intravenous pamidronate treatment in osteogenesis imperfecta","volume":"157","author":"Fujiwara","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.pedneo.2013.12.001_bib13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/JBMR.050213","article-title":"Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome","volume":"20","author":"Munns","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pedneo.2013.12.001_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpeds.2006.03.013","article-title":"Early bisphosphonate treatment in infants with severe osteogenesis imperfecta","volume":"149","author":"Antoniazzi","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2013.12.001_bib15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/adc.2006.096552","article-title":"Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta","volume":"92","author":"Astr\u00f6m","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pedneo.2013.12.001_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1023\/A:1022099425316","article-title":"Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant","volume":"25","author":"Chien","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.pedneo.2013.12.001_bib17","first-page":"76","article-title":"WHO Child Growth Standards based on length\/height, weight and age","volume":"450","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.pedneo.2013.12.001_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1875-9572(10)60014-9","article-title":"New growth charts for Taiwanese children and adolescents based on World Health Organization standards and health-related physical fitness","volume":"51","author":"Chen","year":"2010","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.pedneo.2013.12.001_bib19","first-page":"393S","article-title":"Bone mass in children: normative values for the 2\u201320-year-old population","volume":"16","author":"Zanchetta","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.pedneo.2013.12.001_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S8756-3282(97)00203-2","article-title":"Effect of bone area on spine density in Chinese men and women in Taiwan","volume":"21","author":"Tsai","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.pedneo.2013.12.001_bib21","doi-asserted-by":"crossref","first-page":"672403","DOI":"10.1155\/2012\/672403","article-title":"Normative data for bone mass in healthy term infants from birth to 1 year of age","volume":"2012","author":"Gallo","year":"2012","journal-title":"J Osteoporos"},{"key":"10.1016\/j.pedneo.2013.12.001_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bone.2004.02.023","article-title":"Bone turnover markers in patients with osteogenesis imperfecta","volume":"34","author":"Braga","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.pedneo.2013.12.001_bib23","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","article-title":"Bisphosphonates: mode of action and pharmacology","volume":"119","author":"Russell","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2013.12.001_bib24","first-page":"1846","article-title":"Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age","volume":"85","author":"Plotkin","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pedneo.2013.12.001_bib25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/adc.2007.125468","article-title":"Two doses of pamidronate in infants with osteogenesis imperfecta","volume":"93","author":"Senthilnathan","year":"2008","journal-title":"Arch Dis Child"}],"container-title":["Pediatrics &amp; Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957213002337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957213002337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T00:27:14Z","timestamp":1538872034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957213002337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1875957213002337"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2013.12.001","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclic Pamidronate Infusion for Neonatal-onset Osteogenesis Imperfecta","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2013.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}